Advertisement
Advertisement

Progyny price target raised to $26 from $25 at JPMorgan

JPMorgan analyst Lisa Gill raised the firm’s price target on Progyny (PGNY) to $26 from $25 and keeps a Neutral rating on the shares. The company reported a good Q3 and has positive selling season trends heading into fiscal 2026, the analyst tells investors in a research note.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1